Lupus/SLE
Currently recruiting studies
AbbVie M23-699 (SELECT-SLE) - Phase 3 Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants with Moderately to Severely Active SLE
Investigators: Dr. Ann Clarke, Dr. Megan Barber
Required age range: 18-99
Conditions: Lupus
Currently recruiting: Yes
More information/Key contact: Please email lead investigators for recruitment information.
ASTER: Anifrolumab Study for Treatment Effectiveness in the Real World Multi-National, Observational, Post-Launch Effectiveness Study
Investigator: Dr. Megan Barber
Required age range: 18-99
Conditions: Lupus
Currently recruiting: Yes
More information/Key contact: Visit study website here.
BMS IM011-246 (POETYK SLE-1) - A Phase 3 Study to Evaluate the Safety and Efficacy of Deucravacitinib in Participants with Active SLE
Investigators: Dr. Ann Clarke, Dr. Megan Barber
Required age range: 18-99
Conditions: Lupus
Currently recruiting: Yes
More information/Key contact: Please email lead investigators for recruitment information.
Exploring Newcomer Experiences of SLE: Identifying Priorities and Developing Supports
Investigators: Dr. Ann Clarke, Dr. Megan Barber
Required age range: 18-99
Conditions: Lupus
Currently recruiting: Yes
More information/Key contact: Please email lead investigators for recruitment information.
Healthcare Utilization in Albertan Patients with Positive aPLs/APS and SLE
Investigators: Dr. Ann Clarke, Dr. Megan Barber
Required age range: 18-99
Conditions: APS, Lupus
Currently recruiting: Yes
More information/Key contact: Please email lead investigators for recruitment information.
International Prospective Cohort of SLE Pregnancies and Legacy Biobank
Investigators: Dr. Ann Clarke, Dr. Megan Barber
Required age range: 18-99
Conditions: Lupus, Pregnancy
Currently recruiting: Yes
More information/Key contact: Please email lead investigators for recruitment information.
LUPUS NEXUS LANDMARK STUDY: A PROSPECTIVE REGISTRY AND BIOREPOSITORY
Investigator: Dr. Ann Clarke
Required age range: 18-99
Conditions: Lupus
Currently recruiting: Yes
More information/Key contact: Visit study website here.
Novartis CVAY736K12301 (SIRIUS-LN) - A Phase 3 Study to Evaluate Safety, Efficacy, and Tolerability of Ianalumab in Participants with Active LN
Investigators: Dr. Ann Clarke, Dr. Megan Barber
Required age range: 18-99
Conditions: APS, Lupus
Currently recruiting: Yes
More information/Key contact: Please email lead investigators for recruitment information.
Novartis CVAY736F12301 (SIRIUS-SLE) - A Phase 3 Study to Evaluate Safety, Efficacy, and Tolerability of Ianalumab in Participants with Active SLE
Investigators: Dr. Ann Clarke, Dr. Megan Barber
Required age range: 18-99
Conditions: APS, Lupus
Currently recruiting: Yes
More information/Key contact: Please email lead investigators for recruitment information.
Rheum4U - Precision Health Registry for Inflammatory Arthritis
Investigator: Dr. Dianne Mosher
Required age range: 16-99
Conditions: Gout, Arthritis, Rheumatoid Arthritis, Vasculitis, Lupus, Ankylosing Spondylitis
Currently recruiting: Yes
More information/Key contact: Visit study website here.
Starlet - Southern Alberta Registry for Lupus Erythematosus
Investigator: Dr. Ann Clarke
Required age range: 18-99
Conditions: Lupus
Currently recruiting: Yes
More information/Key contact: Visit study website here.
The Economic Challenges of SLE: Measuring and Mitigating the Impact
Investigators: Dr. Ann Clarke, Dr. Megan Barber
Required age range: 18-99
Conditions: Lupus, SLE
Currently recruiting: Yes
More information/Key contact: Please email lead investigators for recruitment information.
UCB SL0046 - A Phase 3 Extension Study to Assess the Long-Term Safety and Tolerability of Dapirolizumab Pegol Treatment in Study Participants with SLE
Investigators: Dr. Ann Clarke, Dr. Megan Barber
Required age range: 18-99
Conditions: Lupus
Currently recruiting: Yes
More information/Key contact: Please email lead investigators for recruitment information.
World - Southern Alberta Registry for Lupus Erythematosus
Investigator: Dr. Ann Clarke
Required age range: 18-99
Conditions: Lupus
Currently recruiting: Yes
More information/Key contact: Please email lead investigators for recruitment information.